Related Experiment Videos
A novel inositol-containing glycosphingolipid isolated from human peripheral nerve
J E Månsson1, B M Rynmark, L Svennerholm
1Department of Psychiatry and Neurochemistry, University of Göteborg, St. Jörgen Hospital, Hisings-Backa, Sweden.
FEBS Letters
|March 25, 1991
Summary
A novel glycosphingolipid, inositol-phosphoryl-2(3) galactosylceramide, was identified in the human cauda equina. This inositol-phosphate-containing molecule was found at concentrations of 25-30 nmol/g fresh tissue.
Area of Science:
- Biochemistry
- Neuroscience
- Glycosphingolipid research
Background:
- Glycosphingolipids are crucial components of cell membranes.
- The human cauda equina's lipid composition is not fully elucidated.
- Novel lipid structures may play specific physiological roles.
Purpose of the Study:
- To isolate and characterize novel glycosphingolipids from the human cauda equina.
- To determine the structure of any newly identified glycosphingolipids.
- To quantify the concentration of the isolated glycosphingolipid.
Main Methods:
- Isolation of lipids from human cauda equina tissue.
- Structural elucidation using advanced analytical techniques (e.g., mass spectrometry, NMR).
- Quantification of the glycosphingolipid using established biochemical assays.
Main Results:
- A previously unreported glycosphingolipid was successfully isolated.
- The glycosphingolipid was identified as inositol-phosphoryl-2(3) galactosylceramide.
- Concentrations ranged from 25 to 30 nmol/g of fresh tissue.
Conclusions:
- The human cauda equina contains a unique inositol-phosphate-containing glycosphingolipid.
- Inositol-phosphoryl-2(3) galactosylceramide represents a novel biochemical entity in neural tissue.
- Further research is warranted to explore the function of this glycosphingolipid.